COVID-19 Outbreak-Global Gastroesophageal Reflux Disease (GERD) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Gastroesophageal reflux disease ( GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the stomach and esophagus. It occurs when acidic stomach juices, or food and fluids flow back up into the food pipe (esophagus). The backwash irritates the lining of the esophagus and causes GERD. It affects all ages from infants to older adults. The symptoms of GERD include difficulty while swallowing (dysphagia), heartburn sensation, regurgitation or acid reflux, dry cough, sore throat, and chest pain.
The Gastroesophageal Reflux Disease (GERD) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Gastroesophageal Reflux Disease (GERD) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Gastroesophageal Reflux Disease (GERD) market can be split based on product types, major applications, and important countries as follows:

Key players in the global Gastroesophageal Reflux Disease (GERD) market covered in Chapter 12:
Johnson and Johnson
GlaxoSmithKline
SFJ Pharmaceuticals Group
AstraZeneca
Daewoong Pharmaceutical
Vecta Pharmaceuticals
Eisai
Zeria Pharmaceuticals
Takeda
CJ Cheil Jedang

In Chapter 4 and 14.1, on the basis of types, the Gastroesophageal Reflux Disease (GERD) market from 2015 to 2025 is primarily split into:
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
Others

In Chapter 5 and 14.2, on the basis of applications, the Gastroesophageal Reflux Disease (GERD) market from 2015 to 2025 covers:
Hospital
Clinic
Retail Pharmacies
Online Pharmacies

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025